Clinical Trial Update: Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate [NA]

View source ↗

Summary

A completed clinical trial evaluated whether 4 weeks of dihydrocapsiate ingestion affected resting metabolic rate in adults with obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Dihydrocapsiate (dihydrocapsiate)

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Obesity, Weight | NA | Status: COMPLETED